Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19 Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021
Community acquired pneumonia: an increased risk for subsequent cardiovascular events? Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections Year: 2020
Platelet count as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia. Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019
Factors associated with thromboembolic events in patients with pulmonary tuberculosis Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020
Search predictive factors of recurrence in venous thromboembolic disease associated with cancer after withdrawal of the anticoagulation. HISPALIS study Source: International Congress 2016 – Acute pulmonary embolism Year: 2016
Venous thromboembolic (VTE) in patients with ALS: an incidence study Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021
Preventing cardiovascular events after pneumonia with aspirin: one step forward, but still many to go Source: Eur Respir J, 57 (2) 2003778; 10.1183/13993003.03778-2020 Year: 2021
Treatment of latent tuberculosis infection: completion rates and adverse effects Source: Eur Respir J 2003; 22: Suppl. 45, 526s Year: 2003
Long term course of (chronic) thromboembolic pulmonary hypertension, preceded by silent or unrecognized thromboembolic events Source: Annual Congress 2009 - Pulmonary embolism Year: 2009
Predicting adverse events from pulmonary embolism (PE): does the wicki score identify patients suitable for early discharge? Source: Eur Respir J 2003; 22: Suppl. 45, 218s Year: 2003
Management of acute pulmonary thrombo-embolic disease (PTE) linking mortality risk to treatment strategies Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009
Aspirin reduces cardiovascular events in patients with pneumonia: a prior event rate ratio analysis in a large primary care database Source: Eur Respir J, 57 (2) 2002795; 10.1183/13993003.02795-2020 Year: 2021
Severity, risk of progression or thrombosis – what does the D-dimer really reflect in COVID-19 pneumonia? Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021
Frequency of thromboembolic events in patients with lung cancer at the time of diagnosis and in the course of disease Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011
Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension Source: Eur Respir J , 49 (2) 1602522; DOI: 10.1183/13993003.02522-2016 Year: 2017
Incidence of thromboembolic events during first 10 days hospitalization in male pulmonary diseases ward Source: Annual Congress 2009 - Pulmonary embolism Year: 2009
Late Breaking Abstract - Pneumonectomy in patients with reduced pulmonary function: complications and 30-day mortality Source: International Congress 2019 – General thoracic surgery Year: 2019
Recurrence patterns for venous thromboembolism - who is most at risk? Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014
The diagnosis of malignancy following a venous thromboembolic event - how high is the risk? Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014
Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis? Source: Eur Respir J 2016; 47: 369-373 Year: 2016